T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6

Journal of Experimental Medicine

Volumn 179, Issue 5, 1994, Pages 1529-1537

  Mizuhara, Hidekazu ^a   O’neill, Elaine ^a   Seki, Nobuo ^a   Ogawa, Toshikazu ^a   Kusunoki, Chihiro ^a   Otsuka, Kazuyuki ^a   Satoh, Susumu ^a   Niwa, Mineo ^a   Senoh, Hachiro ^a   Fujiwara, Hiromi ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CONCANAVALIN A; RECOMBINANT INTERLEUKIN 6; TACROLIMUS; TUMOR NECROSIS FACTOR;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER INJURY; LIVER PROTECTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIBODIES; CONCANAVALIN A; FEMALE; HEPATITIS, ANIMAL; HUMAN; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR;

EID: 0028300351     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.179.5.1529     Document Type: Article

References (44)

1. Wermers, G.W., H. Band, and E.J. Yunis. 1988. Role of the HLA system in antigen recognition and disease. In The Liver: Biology and Pathobiology. 2nd ed. I. M. Arias, W.B. Jakoby, H. Popper, D. Schächter, and D.A. Shaffitz, editors. Raven Press, New York. 885.
2. Recknagel, R.O. 1987. Carbon tetrachloride hepatoxicity. Pharmacol. Rev. 19:145.
3. Morrison, D.C., and J.L. Ryan. 1987. Endotoxins and disease mechanisms. Amu. Rev. Med. 38:417.
4. Wolff, S.M., and J.V. Benett. 1974. Gram negative rod bacter-aemia (editorial). N. Engl. J. Med. 291:733.
5. Galanos, C., M.A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sei. USA. 76:5939.
6. Lehmann, V., M.A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
7. Keppler, D., R. Lesch, W. Reutter, and K. Decker. 1968. Experimental hepatitis induced by D-galactosamine. Exp Mol. Pathol. 9:279.
8. Tiegs, G., and A. Wendel. 1988. Leukotriene mediated liver injury. Biochem. Pharmacol. 37:2569.
9. Tiegs, G., M. Wolter, and A. Wendel. 1989. Lumor necrosis factor is a terminal mediator in galactosamine/LPS-induced hepatitis in mice. Biochem. Pharmacol. 38:627.
10. Hishinuma, I., J. Nagakawa, K. Hirota, K. Miyamoto, K. Tsu-kidate, T. Yamanaka, K. Katayama, and I. Yamatsu. 1990. Involvement of tumor necrosis factor-a in development of hepatic injury in galactosamine-sensitized mice. Hepatology. 12: 1187.
11. Decker, K., and D. Keppler. 1974. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71:77.
12. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by con-canavalin A. J. Clin. Invest. 90:196.
13. Vink, A., P.G. Coulie, P. Wauters, R.P. Nordan, and J. Van Snick. 1988. B cell growth and differentiation activity of interleukin-HPl and related murine plasmacytoma growth factors: synergy with interleukin 1. Eur. J. Immunol. 18:607.
14. Karmen, A., F. Wroblewski, and J.S. LaDue. 1955. Transaminase activity in human blood. J. Clin. Invest. 34:126.
15. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp Med. 169:333.
16. Cerami, A., and B. Beutler. 1988. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today. 9:28.
17. Freudenberg, M.A., D. Keppler, and C. Galanos. 1986. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51:891.
18. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G. C. Kuo, S.F. Lowry, and A. Cerami. 1987. Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.). 330:662.
19. Cosimi, A.B., R.B. Colvin, R.C. Burton, R.H. Rubin, G. Goldstein, P.C. Kung, W.P. Hansen, F.L. Delmonico, and P.S. Russell. 1981. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N. Engl. J. Med. 305:308.
20. Chatenoud, L., C. Ferran, A. Reuter, C. Legendre, Y. Gevaert, H. Kreis, P. Franchimont, and J.F. Bach. 1989. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma. N. Engl. J. Med. 320:1420.
21. Hirsch, R., R.E. Gress, D.H. Pluznik, M. Eckhaus, andJ.A. Bluestone. 1989. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J. Immunol. 142:737.
22. Ferran, C., K. Sheehan, M. Dy, R. Schreiber, S. Mérité, P. Landais, L.H. Noel, G. Grau, J. Bluestone, J.F. Bach, and L. Chatenoud. 1990. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eut J. Immunol. 20:509.
23. Alegre, M.L., P. Vandenabeele, M. Depierreux, S. Florquin, M. Deschodt-Lanckman, V. Flamand, M. Moser, O. Leo, J. Urbain, W. Fiers, and M. Goldman. 1991. Cytokine release syndrome induced by the 145-201 anti-CD3 monoclonal antibody in mice: prevention by high doses of méthylprednisolone. J. Immunol. 146:1184.
24. Miethke, T, C. Wahl, K. Heeg, B. Echtenacher, P.H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp Med. 175:91.
25. Ferayomi, L.S., P.N. McMillan, L. Raines, C.O. Gerhardt, and H.O. Jauregui. 1983. Lectin binding to adult rat liver in situ, isolated hepatocytes, and hepatocytes cultures. In Isolation, Characterization, and Use of Hepatocytes. R.A. Harris, and N. W. Cornell, editors. Elsevier Science Publishing Co. Inc, New York. 271.
26. Roth, R.A., D.J. Cassell, B.A. Maddux, and J.D. Goldfine. 1983. Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist. Biochem. Biophys. Res. Commun. 115:245.
27. Gilles, P.N., D.L. Guerrette, R.J. Ulevitch, R.D. Schreiber, and F.V. Chisari. 1992. HBsAg retention sensitizes the hépatocyte to injury by physiological concentrations of interferon-γ. Hepatology. 16:655.
28. Mosmann, T.R., and R.L. Coffman. 1989. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
29. Cuturi, M.C., M. Murphy, M.P. CostαGiomi, R. Weinmann, B. Perussia, and G. Trinchieri. 1987. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp Med. 165:1581.
30. Beutler, B., and A. Cerami. 1989. The biology of cachectin/ TNF—α primary mediator of the host response. Annu. Rev. Immunol. 7:625.
31. Paul, N.L., and N.H. Ruddle. 1988. Lymphotoxin. Annu. Rev. Immunol. 6:407.
32. Wong, G.W., and S.C. Clark. 1988. Multiple actions of interleukin 6 within a cytokine network. Immunol. Today. 9:137.
33. Kishimoto, T. 1989. The biology of interleukin-6. Blood. 74:1.
34. Kern, P., C.J. Hemmer, J. Van Damme, H.-J. Grass, and M. Dietrich. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87:139.
35. Starnes, H.F., M.K. Pearce, A. Tewari, J.H. Yim, J.-C. Zou, and J.S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-a challenge in mice. J. Immunol. 145:4185.
36. Aderka, D., J. Le, and J. Vilcek. 1989. IL-6 inhibits lipopoly-saccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:3517.
37. Schindler, R., J. Mancilla, S. Endres, R. Ghorbani, S.C. Clark, and C.A. Dinarello. 1990. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 75:40.
38. Kohase, M., D. Henriksen-DeStefano, L.T. May, J. Vilcek, and P. Sehgal. 1986. Induction of β-2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell. 45:658.
39. Gorgen, I., T. Hartung, M. Leist, M. Niehorster, G. Tiegs, S. Uhlig, F. Weitzel, and A. Wendel. 1992. Granulocyte colony-stimulating factor treatment protects rodents against lipopoly-saccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J. Immunol. 149:918.
40. 2/B cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA. 84:7251.
41. Ruggiero, V., S.E. Johnson, and C. Baglioni. 1987. Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell. Immunol. 107:317.
42. Dett, C.A., M. Gatanaga, E.K. Ininns, F. Cappuccini, R.S. Yamamoto, G.A. Granger, and T. Gatanaga. 1991. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1β, IL-4, and IL-6 in vitro. J. Immunol. 146:1522.
43. Van, B.S., C. Libert, and W. Fiers. 1991. Interleukin-6 enhances the expression of tumor necrosis factor receptors on hepatoma cells and hepatocytes. Cytokine. 3:149.
44. Cairns, J.A., G.R. Guy, and Y.H. Tan. 1992. Interleukin-6 regulates the cytotoxic effect of tumor necrosis factor on U937 cells. Immunology. 75:669.